Moderna Receives FDA Fast Track Designation for Propionic Acidemia Program (mRNA-3927); mRNA-3927 is Moderna's second rare disease program to receive Fast Track designation; mRNA-3927 uses the same proprietary LNP formulation as mRNA-1944 (antibody agains

Media coverage

• Title	Moderna Receives FDA Fast Track Designation for Propionic Acidemia Program (mRNA-3927); mRNA-3927 is Moderna's second rare disease program to receive Fast Track designation; mRNA-3927 uses the same proprietary LNP formulation as mRNA-1944 (antibody agains
  Media name/outlet	Business Wire
  Country/Territory	United States
  Date	22/10/19
  Persons	George Diaz

• Title	Moderna Receives FDA Fast Track Designation for Propionic Acidemia Program (mRNA-3927)
  Media name/outlet	Elk Valley Times
  Country/Territory	United States
  Date	22/10/19
  URL	https://www.elkvalleytimes.com/news/business/moderna-receives-fda-fast-track-designation-for-propionic-acidemia-program/article_ba9c95b6-b07a-5324-a774-c94e589c617e.html
  Persons	George Diaz

• Title	Moderna Receives FDA Fast Track Designation for Propionic Acidemia Program mRNA3927
  Media name/outlet	BioPortfolio
  Country/Territory	United Kingdom
  Date	22/10/19
  URL	https://www.bioportfolio.com/news/article/4116510/Moderna-Receives-FDA-Fast-Track-Designation-for-Propionic-Acidemia-Program-mRNA-3927.html
  Persons	George Diaz